Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;25(2):214-223.
doi: 10.1016/j.jsps.2016.05.005. Epub 2016 Jun 3.

Synthesis and evaluation of anticancer activity of 6-pyrazolinylcoumarin derivatives

Affiliations

Synthesis and evaluation of anticancer activity of 6-pyrazolinylcoumarin derivatives

Yana Garazd et al. Saudi Pharm J. 2017 Feb.

Abstract

A series of novel 6-pyrazolinylcoumarins has been synthesized via multi-step protocol. The synthetic procedure was based on the acetylation of hydroxycoumarins; Fries rearrangement and Claisen-Schmidt condensation; the target 6-[5-aryl-4,5-dihydropyrazol-3-yl]-5-hydroxy-7-methylcoumarins (33-49) were obtained under reactions of hydrazine and 2-aryl-5-methyl-2,3-dihydropyrano[2,3-f]chromen-4,8-diones as the last phase of the protocol. Anticancer activity screening in NCI60-cell lines assay allowed identification of compound 47 with the highest level of antimitotic activity with mean GI50 value of 10.20 μM and certain sensitivity profile toward the Leukemia cell lines CCRF-CEM and MOLT-4 (GI50/TGI values 1.88/5.06 μM and 1.92/4.04 μM respectively).

Keywords: Anticancer activity; Coumarins; Pyrazolines; Pyronoflavanones.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Synthesis of new 6-pyrazolinylcoumarin derivatives.

References

    1. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48(3):589–601. - PubMed
    1. Amin K.M., Eissa A.A.M., Abou-Seri S.M., Awadallah F.M., Hassan G.S. Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. Eur. J. Med. Chem. 2013;60:187–198. - PubMed
    1. Amin K.M., Abou-Seri S.M., Awadallah F.M., Eissa A.A.M., Hassan G.S., Abdulla M.M. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. Eur. J. Med. Chem. 2015;90:221–231. - PubMed
    1. Arshad A., Osman H., Bagley M.C., Lam C.K., Mohamad S., Zahariluddin A.S.M. Synthesis and antimicrobial properties of some new thiazolylcoumarin derivatives. Eur. J. Med. Chem. 2011;46(9):3788–3794. - PubMed
    1. Barot K.P., Jain S.V., Kremer L., Singh S., Ghate M.D. Recent advances and therapeutic journey of coumarins: current status and perspectives. Med. Chem. Res. 2015;24(7):2771–2798.

LinkOut - more resources